[vc_row][vc_column width=”1/6″][/vc_column][vc_column offset=”vc_col-lg-8 vc_col-md-8″][vc_custom_heading text=”The IC-OS Journal Club meets every month in a webinar format to discuss an article related to the most recent scientific developments in cardio-oncology.” font_container=”tag:h6|font_size:24|text_align:center|color:%23dd3333″ use_theme_fonts=”yes” css=”.vc_custom_1587654210608{margin-top: 50px !important;margin-bottom: 20px !important;}”][/vc_column][vc_column width=”1/6″][/vc_column][vc_column][vc_separator color=”custom” border_width=”2″ accent_color=”#dd3333″ el_class=”container” css=”.vc_custom_1566191468918{margin-top: 20px !important;}”][vc_empty_space][/vc_column][/vc_row][vc_row equal_height=”yes” content_placement=”middle” el_class=”container” css=”.vc_custom_1586059803645{margin-bottom: 40px !important;}”][vc_column width=”1/2″][la_heading alignment=”left” title=”April 2020 Journal Club Webinar” title_color=”#12285f”][/la_heading][vc_column_text]Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease.[/vc_column_text][/vc_column][vc_column width=”1/2″ el_class=”seo_features_img”][vc_column_text el_class=”round_circle”][/vc_column_text][vc_column_text][/vc_column_text][/vc_column][/vc_row][vc_row equal_height=”yes” content_placement=”middle” el_class=”container” css=”.vc_custom_1586059803645{margin-bottom: 40px !important;}”][vc_column width=”1/2″][vc_column_text el_class=”round_circle”][/vc_column_text][vc_column_text][/vc_column_text][/vc_column][vc_column width=”1/2″ el_class=”seo_features_img”][la_heading alignment=”left” title=”May 2020 ICOS Monthly Journal Club” title_color=”#12285f”][/la_heading][vc_column_text]Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease[/vc_column_text][/vc_column][/vc_row][vc_row equal_height=”yes” content_placement=”middle” el_class=”container” css=”.vc_custom_1586059803645{margin-bottom: 40px !important;}”][vc_column width=”1/2″][la_heading alignment=”left” title=”June 2020 Journal Club Webinar” title_color=”#12285f”][/la_heading][vc_column_text]
“Neoplasia and the heart: pathological review of effects with clinical and radiological correlation” Presenter: Kalyan R. Chitturi, DO Houston Methodist Hospital
[/vc_column_text][vc_column_text css=”.vc_custom_1591446313249{padding-top: 20px !important;}”]
[/vc_column_text][vc_column_text el_class=”round_circle”][/vc_column_text][/vc_column][vc_column width=”1/2″ el_class=”seo_features_img”][vc_column_text el_class=”round_circle”][/vc_column_text][vc_column_text]
[/vc_column_text][/vc_column][/vc_row][vc_row equal_height=”yes” content_placement=”middle” el_class=”container” css=”.vc_custom_1586059803645{margin-bottom: 40px !important;}”][vc_column width=”1/2″][vc_column_text]
[/vc_column_text][/vc_column][vc_column width=”1/2″][la_heading alignment=”left” title=”August 2020 ICOS Monthly Journal Club Webinar” title_color=”#12285f”][/la_heading][vc_column_text]”Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer”
Dr. Chrisopher Fine, Chief Fellow University of Louisville[/vc_column_text][vc_column_text el_class=”round_circle”][/vc_column_text][/vc_column][/vc_row][vc_row equal_height=”yes” content_placement=”middle” el_class=”container”][vc_column width=”1/2″][la_heading alignment=”left” title=”September 2020 ICOS Monthly Journal Club Webinar” title_color=”#12285f”][/la_heading][vc_column_text]Presenter: Teresa López-Fernández, MDSenior Consultant Cardiologist at La Paz University Hospital (IdiPAz Research Institute,Madrid, Spain).
Article: “Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry”
Cardiotoxicity (CTox) is a major side effect of cancer therapies, but uniform diagnostic criteria to guide clinical and research practices are lacking…Read More[/vc_column_text][/vc_column][vc_column width=”1/2″ css=”.vc_custom_1599282368114{padding-left: 20px !important;}” el_class=”seo_features_img”][vc_column_text el_class=”round_circle”][/vc_column_text][vc_column_text]
[/vc_column_text][/vc_column][/vc_row][vc_row equal_height=”yes” content_placement=”middle” el_class=”container” css=”.vc_custom_1586059803645{margin-bottom: 40px !important;}”][vc_column width=”1/2″][vc_column_text][/vc_column_text][/vc_column][vc_column width=”1/2″][la_heading alignment=”left” title=”November 2020 ICOS Monthly Journal Club Webinar” title_color=”#12285f”][/la_heading][vc_column_text]Presenter: Dr. Talal Al-Otaibi, Cardiac Imaging Fellow
Beth Israel Deaconess Medical Center | Harvard Medical School
Article: Ibrutinib-Mediated Atrial Fibrillation Due to Inhibition of CSK
Read More
[/vc_column_text][vc_column_text el_class=”round_circle”][/vc_column_text][/vc_column][/vc_row][vc_row equal_height=”yes” content_placement=”middle” el_class=”container” css=”.vc_custom_1586059803645{margin-bottom: 40px !important;}”][vc_column width=”1/2″][la_heading alignment=”left” title=”December 2020 ICOS Monthly Journal Club” title_color=”#12285f”][/la_heading][vc_column_text]Article this week: “Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for Prostate Cancer”
Presenter: Dr. Linda Peterson, Washington University in St. Louis School of Medicine
Read More
[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text][/vc_column_text][vc_column_text el_class=”round_circle”][/vc_column_text][/vc_column][/vc_row][vc_row equal_height=”yes” content_placement=”middle” el_class=”container”][vc_column width=”1/2″][vc_column_text][embeddoc url=”https://ic-os.org/new/wp-content/uploads/2020/04/ICOS-Webinar-Prostate-Cancer-Discussion-2020.04.pptx” height=”70%” download=”all” viewer=”microsoft” text=”Download” style=”width:100%;height: 27% !important; border: none;min-height: 298px !important;”][/vc_column_text][/vc_column][vc_column width=”1/2″ css=”.vc_custom_1586060861844{padding-left: 20px !important;}”][la_heading alignment=”left” title=”Ask the Oncologist” title_color=”#12285f”][/la_heading][vc_column_text]
- Does the presence of preexisting CVD affect your decision making for prostate cancer treatment?
- When do you involve a cardiologist or cardio-oncologist for CV risk assessment?
- What are your expectations as an oncologist when you request a CV evaluation?
- What do you need to know before starting treatment?
- How will the results of PRONOUNCE trial affect your clinical decision making for prostate cancer treatment?
[/vc_column_text][/vc_column][/vc_row][vc_row css=”.vc_custom_1586059677392{padding-top: 40px !important;padding-bottom: 40px !important;background-color: #f9f9f9 !important;}”][vc_column][vc_row_inner][vc_column_inner el_class=”section-title”][la_heading title=”Cardiovascular Morbidity in a Randomized Trial”][/la_heading][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner width=”1/4″][/vc_column_inner][vc_column_inner el_class=”member-box” width=”1/2″][la_heading tag=”h4″ title_class=”linkscrol” subtitle_class=”linkscrol”]
2019 – CV morbidity
[/la_heading][la_heading tag=”h6″ title=”RCT comparing GnRH agonist and GnRH antagonist”][/la_heading][/vc_column_inner][vc_column_inner width=”1/4″][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row css=”.vc_custom_1586059677392{padding-top: 40px !important;padding-bottom: 40px !important;background-color: #f9f9f9 !important;}”][vc_column][vc_row_inner][vc_column_inner el_class=”section-title”][la_heading title=”May 2020 ICOS Monthly Journal Club”][/la_heading][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner width=”1/4″][/vc_column_inner][vc_column_inner el_class=”member-box” width=”1/2″][la_heading tag=”h4″ title_class=”linkscrol” subtitle_class=”linkscrol”]
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
[/la_heading][la_heading tag=”h6″ title=”Dr. Courtney Campbell, The Ohio State University”][/la_heading][/vc_column_inner][vc_column_inner width=”1/4″][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]
